Cogent Biosciences (COGT) EBIT Margin (QoQ) (2017 - 2020)
Powered by 
Analysis
Cogent Biosciences (COGT) EBIT Margin (QoQ) (2017 - 2020) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cogent Biosciences | 5.94 Bn | 5.94 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -1.69 Mn |
| Jun 30, 2020 | -131,474.00 |
| Mar 31, 2020 | -10,199.00 |
| Dec 31, 2019 | 119,465.00 |
| Sep 30, 2019 | -84,409.00 |
| Jun 30, 2019 | 5,193.00 |
| Mar 31, 2019 | -15,121.00 |
| Dec 31, 2018 | 28,103.00 |
| Sep 30, 2018 | 4,890.00 |
| Jun 30, 2018 | -25,188.00 |
| Mar 31, 2018 | 939.00 |
| Dec 31, 2017 | -1,648.00 |
| Sep 30, 2017 | -1,741.00 |
| Jun 30, 2017 | 4,200.00 |